NDC 63833-835 - Berinert
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 63833-835
- Package NDCs from labels
- 63833-835-01
- Manufacturer
- CSL Behring GmbH
- Effective date
- 2021-09-21
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Berinert - CSL Behring GmbH | CSL Behring GmbH | 2021-09-21 | PLASMA DERIVATIVE |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 63833-835-01 | Berinert | 10 mL in 1 VIAL | INJECTION, POWDER, LYOPHILIZED, | 10 mL | 500 [iU] in 10mL | 33 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| HUMAN C1-ESTERASE INHIBITOR | ACTIVE INGREDIENT | 6KIC4BB60G | BERINERT (HUMAN C1-ESTERASE INHIBITOR) KIT [CSL BEHRING GMBH] | 20 | |
| HUMAN C1-ESTERASE INHIBITOR | ACTIVE MOIETY | 6KIC4BB60G | BERINERT (HUMAN C1-ESTERASE INHIBITOR) KIT [CSL BEHRING GMBH] | 20 | |
| Glycine | INACTIVE INGREDIENT | TE7660XO1C | BERINERT (HUMAN C1-ESTERASE INHIBITOR) KIT [CSL BEHRING GMBH] | 20 | |
| Sodium Chloride | INACTIVE INGREDIENT | 451W47IQ8X | BERINERT (HUMAN C1-ESTERASE INHIBITOR) KIT [CSL BEHRING GMBH] | 20 | |
| Sodium Citrate | INACTIVE INGREDIENT | 1Q73Q2JULR | BERINERT (HUMAN C1-ESTERASE INHIBITOR) KIT [CSL BEHRING GMBH] | 20 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 249c9738-7dfa-4f18-8330-be14437da235 | 8ea0c7fe-da9d-4218-a080-0509e09bedc6 | 2009-11-10 | Warnings, Adverse reactions | 8ea0c7fe-da9d-4218-a080-0509e09bedc6 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.